Becton, Dickinson and Company Stock
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237.1 USD | +0.35% | +0.08% | -2.75% |
Financials (USD)
Sales 2024 * | 20.24B | Sales 2025 * | 21.42B | Capitalization | 68.29B |
---|---|---|---|---|---|
Net income 2024 * | 2.11B | Net income 2025 * | 2.48B | EV / Sales 2024 * | 4.02 x |
Net Debt 2024 * | 12.96B | Net Debt 2025 * | 10.62B | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
32.5
x | P/E ratio 2025 * |
29.5
x | Employees | 73,000 |
Yield 2024 * |
1.58% | Yield 2025 * |
1.62% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
1 day | +0.35% | ||
1 week | +0.08% | ||
Current month | +1.08% | ||
1 month | +1.39% | ||
3 months | -1.47% | ||
6 months | +1.48% | ||
Current year | -2.75% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
Director of Finance/CFO | 52 | 21-09-05 | |
Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
Director/Board Member | 69 | 10-07-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.40% | 254 M€ | +10.44% | - | |
2.47% | 6 M€ | +16.84% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 237.1 | +0.35% | 967,074 |
24-05-17 | 236.3 | -0.14% | 1,785,047 |
24-05-16 | 236.6 | -0.28% | 1,291,452 |
24-05-15 | 237.3 | +0.97% | 1,168,003 |
24-05-14 | 235 | -0.82% | 1,049,467 |
Delayed Quote Nyse, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.75% | 68.29B | |
-6.23% | 181B | |
+2.59% | 114B | |
+5.32% | 52.24B | |
+7.61% | 44.3B | |
+6.67% | 42.73B | |
+25.17% | 32.52B | |
+20.03% | 26.02B | |
-2.66% | 25.91B | |
-2.18% | 24.72B |
- Stock Market
- Equities
- BDX Stock